ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4,4,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
4,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
4,7,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
5,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
5,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
6,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
8,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
8,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
10,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
11,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
13,2,Bifascicular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
13,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
13,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
14,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
14,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
16,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
19,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
21,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
22,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
23,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
24,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
25,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
25,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
28,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
28,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
28,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
30,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
30,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
30,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
30,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
31,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
32,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
32,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
34,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
34,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
35,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
35,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
35,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
36,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
37,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
38,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
38,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
38,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
38,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
39,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
39,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
42,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
44,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
44,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
45,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
46,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
48,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
49,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
50,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
50,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
53,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
53,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
53,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
53,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
53,6,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
53,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
54,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
55,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
56,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
56,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
56,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
56,7,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
56,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
56,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
57,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
57,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
58,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
58,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
60,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
61,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
61,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
61,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
61,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
62,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
65,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
65,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
68,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
70,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
71,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
72,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
73,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
74,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
74,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
74,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
75,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
75,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
76,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
77,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
77,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
78,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
79,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,Y
80,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
80,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,2,Headache,Headaches NEC,Headaches,Nerv,N
82,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
83,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
83,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
83,3,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
84,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,3,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
86,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
86,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
88,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
88,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
89,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
89,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
90,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
90,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
90,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
91,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
91,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
92,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
93,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
94,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
95,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
95,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
96,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
97,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
100,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
100,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
101,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
102,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
103,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
104,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
105,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
107,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
